FSD PHARMA INC-CLASS B (HUGE) Forecast, Price Target & Analyst Ratings

NASDAQ:HUGE • CA35954B4047

Current stock price

0.0899 USD
-0.01 (-10.1%)
At close:
0.0916 USD
+0 (+1.89%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FSD PHARMA INC-CLASS B (HUGE).

Forecast Snapshot

Consensus Price Target

Price Target
$7.83
+ 8,606.04% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2024
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.83
Upside
+ 8,606.04%
From current price of $0.09 to mean target of $7.83, Based on 7 analyst forecasts
Low
$7.75
Median
$7.83
High
$8.06

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for HUGE. The average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HUGE Current Analyst RatingHUGE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

HUGE Historical Analyst RatingsHUGE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
HUGE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HUGE.
In the previous month the buy percentage consensus was at a similar level.
HUGE was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2024

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2023

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023
Revenue
YoY % growth
HUGE revenue by date.HUGE revenue by date.
66.482K188.324K
183.27%
-100.00%		N/AN/AN/A
EBITDA
YoY % growth
HUGE ebitda by date.HUGE ebitda by date.
N/A-24.412M-23.763M
2.66%		N/A
-9.17%		N/A
-14.47%		N/AN/A
EBIT
YoY % growth
HUGE ebit by date.HUGE ebit by date.
-2.659M
-1,906.82%		-24.549M
-823.13%		-26.12M
-6.40%		N/A
-14.25%		N/A
-13.07%		N/AN/A
Operating Margin
HUGE operating margin by date.HUGE operating margin by date.
N/A-36,925.57%-13,869.79%N/AN/AN/AN/A
EPS
YoY % growth
HUGE eps by date.HUGE eps by date.
N/AN/AN/A-352.72
14.05%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HUGE Yearly Revenue VS EstimatesHUGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 100K 200K 300K
HUGE Yearly EPS VS EstimatesHUGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 -100 -200 -300 -400

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FSD PHARMA INC-CLASS B / HUGE Forecast FAQ

What do analysts expect the price target to be for FSD PHARMA INC-CLASS B (HUGE)?

7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.

What is the next earnings date for HUGE stock?

FSD PHARMA INC-CLASS B (HUGE) will report earnings on 2024-11-12, before the market open.

What is the consensus rating for HUGE stock?

The consensus rating for FSD PHARMA INC-CLASS B (HUGE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.